The University of Southern Mississippi

The Aquila Digital Community
Honors Theses

Honors College

Spring 5-2019

The DNA Damage Response Gene DDR48 Regulates Sterol
Synthesis Genes to Confer Antifungal Resistance to the
Pathogenic Fungus Histoplasma capsulatum
Gabriella Reyes
University of Southern Mississippi

Follow this and additional works at: https://aquila.usm.edu/honors_theses
Part of the Molecular Biology Commons

Recommended Citation
Reyes, Gabriella, "The DNA Damage Response Gene DDR48 Regulates Sterol Synthesis Genes to Confer
Antifungal Resistance to the Pathogenic Fungus Histoplasma capsulatum" (2019). Honors Theses. 687.
https://aquila.usm.edu/honors_theses/687

This Honors College Thesis is brought to you for free and open access by the Honors College at The Aquila Digital
Community. It has been accepted for inclusion in Honors Theses by an authorized administrator of The Aquila
Digital Community. For more information, please contact Joshua.Cromwell@usm.edu.

The University of Southern Mississippi

The DNA Damage Response Gene DDR48 Regulates Sterol Synthesis Genes to Confer
Antifungal Resistance to the Pathogenic Fungus Histoplasma capsulatum

by

Gabriella M. Reyes

A Thesis
Submitted to the Honors College of
The University of Southern Mississippi
in Partial Fulfillment
of Honors Requirements

May 2019

i

ii

Approved by

Glenmore Shearer, Ph.D., Thesis Adviser
Professor of Biological Sciences

Jake Schaefer, Ph.D., Interim Director
School of Biological, Environmental,
and Earth Sciences

Ellen Weinauer, Ph.D., Dean
Honors College

iii

Abstract

Histoplasma capsulatum is a dimorphic fungal pathogen that is endemic to the
Ohio, Missouri, and Mississippi river valley regions. The fungus grows as a mold at
environmental temperatures (25C) and transforms into a unicellular yeast upon
inhalation by a mammalian host (37C). The mold to yeast shift is required for
pathogenicity in host organisms, where the potentially fatal disease, histoplasmosis, can
present. This study aims to characterize the DNA damage response protein DDR48 and
the role that it plays in combating cellular stressors in H. capsulatum. We found that
DDR48 is expressed strongly in the mold phase but expressed only at basal levels in the
yeast phase. However, DDR48 expression is significantly upregulated in the yeast phase
under stressful conditions, like antifungal stress. We found that wild-type H. capsulatum
yeast exposed to the antifungal drugs ketoconazole or Amphotericin-B upregulated
DDR48 expression (assayed via qRT-PCR) at least 4-fold. The mold growth form,
however, showed no significant change in expression of DDR48 under these conditions.
Additionally, the DDR48 knockout mutant previously created in our lab was significantly
more sensitive to these antifungal drugs. The knockout cells also experienced
dysregulation of their membrane sterol synthesis genes, indicating a potential role of
DDR48 in conferring antifungal resistance to H. capsulatum by acting as a regulator of
membrane maintenance and integrity. Research is ongoing to further elucidate the role of
DDR48 in the stress response pathway of this common human pathogen.
Key Words: Histoplasma capsulatum, DDR48, Amphotericin-B, ketoconazole,
antifungal resistance, ergosterol
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Chapter I: Introduction
The aim of this study is to investigate the role that the DNA response protein, DDR48,
plays within the fungal pathogen, Histoplasma capsulatum, by quantifying its expression levels
in response to antifungal drug exposure, as well as observing expression changes in other genes
within the cell when DDR48 is deleted from the genome. Because of the ability of H. capsulatum
to infect humans and cause the potentially fatal pulmonary disease, histoplasmosis, there is an
interest in determining the function of DDR48 and the role that it may possibly play in conferring
antifungal resistance to the organism. The findings may contribute to further developing
antifungal treatments to combat the organism. This study examines how DDR48 expression
levels change in response to antifungal drugs, the doses of antifungal drugs needed to inhibit
growth of wild-type and DDR48 deletion mutant cells, and, lastly, expression changes in
ergosterol synthesis genes in a non-DDR48 expressing strain of H. capsulatum.
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Chapter II: Literature Review
Kingdom Fungi is one of the most diverse kingdoms of life on earth, encompassing
approximately 1.5 million species, each with its own morphology, life cycle, and metabolism
(Lutzoni et al., 2004). Fungi are capable of both parasitic and symbiotic relationships with plants
and insects, as demonstrated by the ability of Metarhizium, for example, to parasitically digest
insects while also transferring nitrogen and other nutrients to the plant(s) with which it associates
(Behie, Zelisko, & Bidochka, 2012). The four major groups that have been established in
Kingdom Fungi are the Chytridiomycota, Zygomycota, Ascomycota, and Basidiomycota, though
more recent proteome studies suggest that Chytridiomycota and Zygomycota may fall under the
larger Monokarya clade (Choi & Kim, 2017). Chytridiomycota consists of unicellular or
filamentous fungi that feature flagellated cells and normally reside in aquatic environments.
Zygomycota comprises a wide array of filamentous species that include soil saprobes, and
symbionts of arthropods and plants. Zygomycetes lack flagella, as do Ascomycetes and
Basidiomycetes, while the latter two kingdoms also exhibit the unique morphology of both
single-celled growth and multi-celled, mycelial growth (Lutzoni et al., 2004). Basidiomycota are
characterized as fungi that produce fruiting bodies, such as the “pedestal” structure of a typical
mushroom. Ascomycota fungi are very diverse in morphology and produce spores that reside
inside sacs called “asci,” that are released during reproductive cycles (Lutzoni et al., 2004).
Ascomycota is the largest phylum of fungi, consisting of over 64,000 species and nearly
40% of all discovered fungi. They are found in a broad range of ecosystems across the globe,
ranging from the inside of frozen rock in Antarctica to the depths of the sea in fallen wood
fragments (Schoch et al., 2009). They are utilized in many industrial and agricultural settings,
producing many foodstuff products on which humans have become reliant. Saccharomyces
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cerevisiae has become widely used to make fermented food and beverage products including
beers, wines, cheeses, and breads, due to its ability to ferment different carbohydrate sources
(Bokulich & Bamforth, 2013). While Ascomycota pose many benefits to humans externally in
the manufacturing industry, some species can also reside internally as part of a commensal
relationship with the human host, possibly resulting in a parasitic relationship under certain
conditions.
The spores found within the asci of Ascomycetes are major contributors to the spread of
the organism and permit inhalation by host organisms. Candida albicans is a well-known
opportunistic fungal pathogen that exists as a member of the normal human flora and maintains a
commensal relationship with its host. Environmental changes, however, can trigger the activity
of virulence factors, thereby allowing the organism to invade and infect host tissue. Another
pathogenic Ascomycete is Histoplasma capsulatum, whose pathogenicity is similarly activated
when subjected to certain virulence factors (Maresca & Kobayashi, 1989).
Histoplasma capsulatum is endemic to the Ohio, Mississippi, and Missouri River valley
regions and is thermally dimorphic, meaning it exists in both mold and yeast forms depending on
the temperature in which the organism is cultured. Studies have demonstrated that at
environmental temperatures (~25°C), multicellular mold growth will occur, whereas at the
average mammalian host temperature (37°C), the unicellular yeast form will instead occur. This
mold-to-yeast shift, primarily triggered by the temperature increase, is essential for the
pathogenicity of the organism (Maresca & Kobayashi, 1989). Once in the yeast form, H.
capsulatum utilizes several mechanisms to evade the host immune response. One such
mechanism is the concealment of its cell wall -glucans, which are easily recognized by the
Dectin-1 receptor on host macrophages. The pathogen achieves this feat by producing a layer of
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 1-3-glucan molecules to mask the -glucans (Domer, 1971). Utilizing this virulence factor, the
pathogenic organism may then colonize within the host macrophage and replicate within the
phagolysosome to eventually infect lung tissue. Invasion of the lungs spurs the onset of
histoplasmosis, the most common pulmonary mycosis in the United States (Benedict & Mody,
2016).
Micro- and macroconidia of H. capsulatum are regularly inhaled by natives of the
organism’s endemic regions due to environmental disruptions of the soil. In fact, it is believed
that more than 40 million people in the United States have been infected with H. capsulatum
(Zarnowski, Miyazaki, Dobrzyn, Ntambi, & Woods, 2007). This organism is a primary fungal
pathogen, meaning it has the potential to infect any individual, regardless of their health status.
Patients need not be immunosuppressed to experience symptoms of disease, as is the case with
some other opportunistic fungi, such as Cryptococcus neoformans (Walsh & Dixon, 1996).
However, infected individuals often remain asymptomatic, unaware of the self-limiting disease.
The majority of those infected show mild symptoms such that an estimated 95% of
histoplasmosis cases are not diagnosed (Zarnowski et al., 2007). For those experiencing mild
symptoms of acute pulmonary histoplasmosis, fever, headaches, dry cough, and general lethargy
may present, which the individual may mistakenly attribute to the common cold. This selflimited disease has the ability to resolve itself, unlike the more severe, disseminated form of
histoplasmosis. Specifically, patients who are immunocompromised, such as those infected with
HIV, transplant recipients, those undergoing cancer treatments or receiving any other
immunosuppressive treatments are at the highest risk for severe infections (Assi et al., 2013).
Histoplasma capsulatum also possesses the ability to survive within macrophages, which then
spread throughout the body via the lymphatic system, granting the organism access to every
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organ system in the body (Kauffman, 2007). As modern medical advances produce new
therapies to combat histoplasmosis, awareness of the disease is becoming more prevalent,
thereby stressing the importance of understanding the mechanisms that H. capsulatum uses to
survive in the harsh host environment.
When under stress-inducing or exposed to DNA damaging agents, various stress response
pathways in H. capsulatum may be activated. One such mechanism in fungi involves a family of
proteins called the DNA damage response (DDR) protein group, which responds to damage
caused by various stressors acting upon the cell. When there are breaks or other mutations in the
DNA, DDR genes and proteins are recruited to initiate the signaling and repair process of the
damage (Polo & Jackson, 2011). One specific protein in this family, DDR48p, has been shown to
be upregulated during filamentation and biofilm formation in C. albicans, but its true function
still remains unknown. DDR48 has also shown increased transcription in response to DNA
lesion-producing agents, osmotic stress, and heat shock in S. cerevisiae (Cleary, MacGregor,
Saville, & Thomas, 2012). A homologous gene has been isolated in H. capsulatum, DDR48, and
has been shown to respond to stressors including DNA damage. This gene has not been
extensively studied in H. capsulatum, so understanding more about the role it plays in the stress
response pathway of the organism is of particular interest.
Though much research has been conducted on H. capsulatum, there is still far more to
learn regarding its gene and protein expression, virulence, and survival mechanisms. On the
molecular level, there is considerable focus on the signaling mechanisms that the organism uses
to combat stress and survive. As mentioned previously, DDR48 in H. capsulatum shares
sequence homology with DDR48 in C. albicans and S. cerevisiae, where the protein has been
shown to respond to stress-inducing agents. DDR48p has been found to be a stress response
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protein in these organisms that is utilized when the cell faces oxidative stress, cell walldisturbing agents, and antifungal drugs, but to be nonessential for survival (Dib, Hayek, Sadek,
Beyrouthy, & Khalaf, 2008). In C. albicans, DDR48p has even been suggested to be involved in
conferring resistance to antifungal drugs, which, along with assisting in biofilm formation,
increases the pathogenicity of the fungus (Cleary et al., 2012). Furthermore, if DDR48p is able to
sense changes in the environment, then it may function farther beyond the general stress
response and contribute to the overall pathogenicity of the organism.
The aim of this study is to investigate the role that DDR48 plays within H. capsulatum by
quantifying its expression levels in response to antifungal drug exposure, as well as observing
the effects on other genes within the cell when DDR48 is deleted from the genome. The drugs
used in this study are two that are commonly used in the clinical setting to treat histoplasmosis:
Amphotericin-B and ketoconazole (Assi et al., 2013; Hage et al., 2009). Amphotericin-B is an
intravenously administered antifungal medication that binds irreversibly to the ergosterol found
in the cell membranes of H. capsulatum, forming pores and disrupting membrane integrity by
allowing the leakage of ions out of the cell. Its mechanism of action is illustrated in Figure 1.
Ketoconazole is an imidazole-based antifungal agent that is administered orally as a tablet and
interferes with the synthesis of ergosterol by inhibiting the enzyme, cytochrome P450 14demethylase. This enzyme is pivotal in converting lanosterol to another precursor of ergosterol in
the ergosterol biosynthesis pathway, ultimately contributing to membrane maintenance and
integrity for H. capsulatum.
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Figure 1. The mechanism of Amphotericin-B acting on a yeast cell.
By subjecting yeast phase H. capsulatum cells to these antifungals and observing the
subsequent transcriptional responses, more may be uncovered about the function of DDR48.
Additionally, since the two chosen antifungals interfere with the synthesis of ergosterol, certain
genes in the ergosterol synthesis pathway were selected so that their expression levels may be
observed when DDR48 is and is not present in the cell. In doing so, the role of DDR48 as a
possible regulator of the ergosterol synthesis pathway may be investigated.

Chapter III: Methodology
Cell Culturing
H. capsulatum cells were cultured in Histoplasma Macrophage Medium (HMM), a
modified tissue culture medium designed to mimic growth in vivo (Worsham & Goldman, 1988).
The components of this medium consist of the following, per liter: 10.7 g F12 Nutrient Mix
7

(Sigma-Aldrich Chemical Company, St. Louis, MO #N6760), 18.2 g D-glucose, 1.0 g Lglutamic acid, 5.96 g HEPES buffer, and 84 mg L-cysteine. The pH was adjusted to 7.5, and the
medium was filter sterilized and stored at 4C. The H. capsulatum clinical isolate G186A
(ATCC 26027) was the wild-type background strain used in this study. WU27 was constructed
from this strain, which features a spontaneous smooth phenotype and ura5-deletion (Klimpel &
Goldman, 1987). Table 1 lists the strains constructed from WU27. Both mold and yeast cells
were cultured in HMM that was supplemented with 50 g/mL ampicillin and 100 g/mL
streptomycin to reduce bacterial contamination. Cultures for uracil auxotrophs were also
supplemented with 100 g/mL uracil. All yeast cultures were grown at 37C in 5% CO2/95%
room air with shaking at 200 rpm. Mold phase cultures were grown at 25C in room air with
shaking at 200 rpm.
Strain

Genotype

Other Designation

G186A

wild-type (ATTC# 26027)

WU27

ura5-D32

WT, DDR48(+)

USM10

ura5-D32 / ddr48-D1::hph

ddr48∆

USM13

ura5-D32 / ddr48-D1::hph

ddr48∆ + DDR48

+ pLE4 [URA5, DDR48]
Table 1. Strains constructed from WU27.
Nucleic Acid Extraction
Total RNA from mold phase cells was extracted as follows: 150 mL mycelial cultures
were grown for 10 days at 25oC and harvested by vacuum filtration onto a Whatman, Grade No.
1, 11 m filter paper. Cells were washed with cold 1X PBS (0.137 M NaCl, 0.0027 M KCl, 0.01
M Na2HPO4, 0.0018 M KH2PO4) (pH 7.4) and removed with a sterile cell lifter. Yeast cells were
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grown to exponential phase (OD600 1.2-1.8) and collected via centrifugation at 500 x g and
resuspended in cold, sterile H2O. Cells were recovered again via centrifugation at 500 x g and
resuspended in the RNA extraction cocktail described below.
To extract the RNA from mold and yeast phase cells, glass beads were used in acid
phenol to gently lyse the cell and release its contents. Yeast or mold cells were resuspended in a
2-ml screw-top microcentrifuge tube in 300 L of RNA extraction buffer (0.1 M Na acetate, 0.2
M NaCl (pH 5.0), 0.2% SDS), 300 L phenol: chloroform (5:1, pH 4.5), and 200 L 0.5 mm
acid-washed glass beads. RNase inhibitor and DNase I were also added to this mixture, in
quantities of 0.25 L each. The tubes were then placed on a MP Fast Prep-24 vortexer (MP
Biomedicals) to shake at 4.0 m/s in 20-second intervals with 1 minute of resting on ice between
each interval. For yeast, 4 cycles were used, and 6-8 cycles were used for mold. The samples
were then centrifuged at 10,000 x g for 10 minutes at 4C to pellet the cell debris and separate
the aqueous phase that would contain the RNA from the organic phase. The aqueous phase was
recovered and transferred into a new 1.5-mL microcentrifuge tube containing 1 mL of cold 100%
ethanol. Samples were stored at -80C overnight to precipitate the RNA.
RNA was purified for use in qPCR as follows: RNA samples were removed from -80C
storage and centrifuged at 12,000 x g for 10 minutes at 4C. The supernatants were removed, and
the RNA was allowed to air dry before being resuspended in 50 L of Tris-EDTA (TE) buffer
(10 mM Tris-HCl (pH 8.0) and 0.1 mM EDTA). The NanoDrop™ spectrophotometer
(ThermoFisher Scientific) was used to quantify the concentration of RNA in each sample and
assess quality via calculating the 260 nm/280 nm absorbance ratio. To remove harmful DNases,
the following components were then added to a 0.6 ml centrifuge tube: 10 g of RNA, 5 L 10X
TURBO DNase I Buffer (Ambion), 1 L TURBO DNase (Ambion), and sterile H2O to bring the
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final volume to 50 L. The samples were incubated at 37C for 30 minutes. Then, 5 L of
DNase Inactivation Reagent (Ambion) were added to each sample, and the samples incubated at
25C for 2 minutes. They were then centrifuged at 10,000 x g for 1.5 minutes to pellet the
inactivation reagent. The resulting DNA-free RNA was used to synthesize cDNA with the
Maxima First Strand cDNA Synthesis Kit (ThermoFisher Scientific) according to the
manufacturer’s directions.
The purified RNA was quantitated with the NanoDrop™ spectrophotometer (A260 and
A280 measurements) and 500 ng of purified RNA was added to a new 0.6 mL centrifuge tube
with the following components: 1 L 10X dsDNase Buffer, 1 L dsDNase, and sterile H2O to
bring the final volume to 10 L. The samples were incubated for 2 minutes at 37C. Then, to the
same tubes, 4 L 5X Reaction Mix, 2 L Maxima Enzyme Mix, and 4 L H2O were added. The
samples were incubated at 25C for 10 minutes and 50C for 30 minutes, then the reaction was
terminated by heating at 85C for 5 minutes. Synthesized cDNA was then stored at 4C until
needed.
Quantitative Real Time-Polymerase Chain Reaction
The cDNA was quantitated with the NanoDrop™ and sterile type 1 H2O was added to
yield a final concentration of 250 ng/L. One L (250 ng) was used as template for quantitative
real-time PCR (qRT-PCR) analysis. Reactions were performed in triplicate for each gene of
interest. A SYBR Green-based Master Mix (Maxima) was utilized, and a master mix was created
containing the SYBR, cDNA, forward and reverse primers, and nuclease-free H2O for each gene.
For four reactions per gene (three replicates and one additional reaction to account for error), the
master mix contained 4 L cDNA (250 ng/reaction), 4 L forward primer, 4 L reverse primer,
38 L nuclease free H2O, and 50 L SYBR. 25 L of this mix was then pipetted into 3 sterile
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tubes on an 8-tube PCR strip for each gene being studied. The tubes were placed in a CFX96
Touch Real-Time PCR Detection System (BioRad) to undergo the following steps: initial
denaturation at 95C for 10 minutes; 30 repeats of denaturation at 95C for 10 seconds,
annealing at 60C for 30 seconds, and extension at 72C for 30 seconds. The integrity of each
cycle was measured by melt-curve analysis. Relative expression was determined using the Ct
method after normalizing to levels of Histone H3 transcript.
Validation of DDR48 Mutant Strains
Previously, the laboratory created several supplemental variants of Histoplasma
capsulatum to study DDR48. The first strain utilized for this project was a “knockout” strain
(ddr48) featuring allelic replacement of DDR48 with the hygromycin resistance gene (hph),
and the second was a “complement” strain (ddr48 + DDR48), in which DDR48 was returned to
ddr48 cells on a plasmid to confirm that any changes seen in the deletion mutant were restored
when DDR48 was returned and expressed in the cell.
These strains were confirmed at the genomic and transcriptional level. RNA was
extracted from WU27 (DDR48(+)), USM10 (ddr48), and USM13 (ddr48 + DDR48) H.
capsulatum cells as described above. Purified RNA underwent reverse transcription, and the
cDNA was used in qRT-PCR to determine if DDR48 was functionally transcribed in these strains
(results depicted in Figure 2b).
Antifungal Susceptibility
To further elucidate the function of DDR48 in H. capsulatum, WU27, USM10, and
USM13 cells were stressed with two antifungal agents: Amphotericin-B (5 g/mL) and
ketoconazole (50 g/mL). The purpose of these assays was to examine the potential role of
DDR48 in the stress-response of the cell. That is, following the addition of antifungal drugs,
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DDR48 was analyzed for upregulation, which would indicate a potential role in conferring
antifungal resistance to the organism. RNA was extracted from mold and yeast cells at different
timepoints following the addition of the drugs at 15, 30, 60, and 120 minutes utilizing the
previously described methods. RNA purification and cDNA synthesis similarly followed as
described. qRT-PCR yielded the results depicted in Figure 4. Each concentration was tested
with three biological replicates of wild-type H. capsulatum cells.
To further investigate DDR48’s potential role in cell wall regulation, ergosterol synthesis
genes were studied in cells with and without a functional copy of DDR48 once again using qRTPCR. WU27, USM10, and USM13 cells were grown to mid-log phase, Amphotericin-B (5
g/mL) and ketoconazole (50 g/mL) were added, and RNA extraction, purification, and cDNA
synthesis were performed as detailed above. For qRT-PCR, the primers listed in Table 2 were
used to elucidate differential expression of genes in the ergosterol synthesis pathway.
Susceptibility to Amphotericin-B and Ketoconazole
To examine how the growth of H. capsulatum cells was affected by the presence of
Amphotericin-B, a microplate dose-response assay was performed, adapted from the methods of
Goughenour, Balada-Llasat, & Rappleye (2015). Cells were grown to mid-log phase (OD600 1.41.9), enumerated in a hemocytometer, and diluted to 4 x 106 cells/mL in 2X HMM. Cells were
added to the wells of a 96-well, flat-bottomed microplate. Amphotericin-B concentrations were
prepared at twice the desired concentrations (two-fold dilutions from 32 g/mL to 0.02 g/mL
final concentrations). Then, 50 L of HMM medium with or without Amphotericin-B were
added to each well, for a total volume of 100 L. A multi-channel micropipette was used to
gently mix the volume in each well. The microplates were covered with their lids and sealed with
Blenderm (3M) breathable tape to be placed in the 37C incubator for 4 days. Twice daily, the
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plates were aerated by rocking on a benchtop rocker for 30 minutes. Growth was then quantified
by the measurement of turbidity of each well at OD600 with a microplate reader. GraphPad Prism
software was then utilized to calculate an IC50 curve from the dose-response data by nonlinear
regression. This protocol was repeated using ketoconazole as the stressor. Final concentrations
ranged from 32 g/mL to 0.02 g/mL, as well.
Primer
Erg2
Erg3
Erg4
Erg5
Erg6
Erg7
Erg11a
Erg11b
Erg24
Erg25
Erg26
Srb1
H3
DDR48

Sequence
F – TTCAGCAACCACGGAAAC – (Tm = 57.5)
R – CGCCATGCAGTATCGTAAA – (Tm =57.2)
F – GGATTATGCCAAGCCCTTAC – (Tm = 57.8)
R – CAGGACAGTCCAGATGTTAATG – (Tm = 57.8)
F – GTACATCGTCTATCTGTTTGTTTAC – (Tm = 60.0)
R – GCATATCCATACCACCCATC – (Tm = 59.9)
F – CCACCATCTTCACCATCTTG – (Tm = 60.5)
R – CGACGAACTTGTGGAAGAC – (Tm = 60.4)
F – CTCTTACGCGACATTACTACAA – (Tm = 60.1)
R – CCACAGCCTACATCAAGAAC – (Tm = 60.4)
F – GGCACCTGTATGAACTACAC– (Tm = 60.1)
R – GGAAGCAACCAGAGTTCAG – (Tm = 60.2)
F – TTCTTGGAACAAAAGGCAACG  (Tm = 59.2)
R – CGAGGTTAGCCCGTATTTGAC  (Tm = 60.1)
F – CTATGGAACCGACCCGTATAAG  (Tm = 59.1)
R – TCGTTGCCCTTTATGCCTAG  (Tm = 59.3)
F – CCTTCTACTCTTGTGCTTGATAC – (Tm = 60.6)
R – AGTGGTAAGAAAGGTGTTGAAT – (Tm = 60.4)
F – GCAATAAAATCCCTAGCCTGAAG  (Tm = 58.8)
R – TTTGATAAGTCATAGTCCACGGG  (Tm = 59.4)
F – TATACAGAGACGAAGGCCCAA – (Tm = 62.7)
R – GAGGACGAATGGAGAGGATTTG – (Tm = 62.4)
F – GTAGCAGCCGAACAACATCTG – (Tm = 60.8)
R – AATGAGACCTTGGGCGATACG – (Tm = 61.7)
F – TGGTAAGGTCCCTCGTAAGC – (Tm = 60.6)
R – GGAGTTTGCGGATGAGGAG – (Tm = 59.5)
F – GACAATACTACCACCTATGGGTCTAA – (Tm = 60.8)
R – CTTATCAGCGATGGTTTCCTTCTG – (Tm = 60.8)
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Table 2. Primers used for qRT-PCR with melting temperatures (Tm) shown. All
PCR products were approximately 200 bp in length.
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Chapter IV: Results and Discussion
To analyze basal expression levels of DDR48 in H. capsulatum mold and yeast cells
under optimal growth conditions, RNA was extracted from wild-type strains and analyzed via
qRT-PCR, as described above. Northern blot analyses were performed on the RNA to visualize
the abundance of DDR48 transcripts. The results are depicted in Figure 2a. It can be seen that
expression of DDR48 in the mold morphotype is nearly 6-fold greater than that in the yeast
morphotype under normal conditions.
Allelic replacement of the DDR48 gene yielded the strain USM10, also referred to as the
knockout strain or ddr48. Constructing a plasmid containing DDR48 and adding it to the
knockout strain yielded USM13, also referred to as the complement strain or ddr48 + DDR48.
The purpose of creating these strains was to ensure that changes in subsequent assays seen
between the wild-type and knockout strains were truly due to the absence of DDR48 by ensuring
that the phenotype in question was restored in the complement strain. These constructs were
created previously in the lab, but qRT-PCR and Northern blotting techniques (Figure 2b)
validated that the strains were created successfully. DDR48 is absent in ddr48, as seen by the
lack of expression in the qRT-PCR assays and the lack of transcripts in the northern blot, while
expression is restored in both instances in the complement strain.
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Figure 2. DDR48 expression in mold vs. yeast morphotypes. a. qRT-PCR
assays and Northern blot analysis were performed on mold and yeast from two
wild-type, DDR48-expressing strains. Histone H3 was used as a normalizer gene
for Northern blot loading. b. qRT-PCR assays and Northern blot analysis were
performed on wild-type, ddr48 allelic replacement mutant, and ddr48 + DDR48
complement strains. Histone H3 was used as a normalizer gene using the ct
method to normalize to wild-type DDR48 (+) expression. All experiments were
performed with at least three biological replicates. Data from replicates are graphed
as mean ± standard deviation.

Since DDR48 gene expression is known to respond to antifungals in C. albicans, we
exposed yeast phase H. capsulatum cells to Amphotericin-B and ketoconazole to determine if
similar results would be achieved in this fungus. Dose-response analyses demonstrated
susceptibility of yeast phase H. capsulatum cells to these antifungals (Figure 3). This data was
then used to identify the minimum inhibitory concentration (MIC) of each drug for each strain,
or the lowest concentration of drug that inhibited visible H. capsulatum growth. The half
maximal inhibitory concentrations (IC50), doses required to inhibit the growth of H. capsulatum
by 50%, were also calculated. It was clear that wild-type cells could tolerate the additional stress
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imparted by higher drug concentrations better than could knockout cells, which were more
sensitive. Specifically, knockout cells subjected to Amphotericin-B stress were inhibited by drug
concentrations that were three times lower than those required to inhibit wild-type growth. For
ketoconazole, the MIC for knockout cells was approximately 50% that for wild-type cells.
Additionally, the IC50 value for knockout cells under Amphotericin-B stress was 0.06 g/mL
compared to that for wild-type cells at 0.24 g/mL. Ketoconazole stress resulted in an IC50 value
of 0.48 g/mL in knockout cells compared to 1.56 g/mL in wild-type cells. For each
experiment, resistance was restored in the complement strain; thus, knockout cells were more
susceptible to antifungal drugs due to the loss of DDR48.
Next, we chose to use the same antifungals to compare DDR48 expression levels between
mold and yeast H. capsulatum cells. Recalling that basal transcriptional expression levels of
DDR48 in mold phase cells were nearly 6-fold higher than in yeast cells (Figure 2a), the aim
was to determine how DDR48 expression in each morphotype changed under antifungal
stressors. RNA was extracted from mold and yeast cells at 0, 0.25, 0.5, 1, and 2 hour timepoints,
respectively, and analyzed via qRT-PCR (Figure 4). Interestingly, we found that even under
antifungal stress, DDR48 was constitutively expressed in the mold phase. The yeast morphotype,
however, exhibited significant up-regulation of DDR48 expression in response to these stressors.
Due to the expressional response observed, it appears that DDR48 may contribute to combating
the stress inflicted on the yeast morphotype and may help confer antifungal resistance to the
organism.
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Figure 3. The DDR48 deletion mutant is more susceptible to antifungal drugs
than the wild-type strain. Dose-response curves for Amphotericin-B (a) and
ketoconazole (b) for wild-type, knockout, and complement strains. Half maximal
inhibitory concentrations (IC50) and minimum inhibitory concentrations (MIC) of
Amphotericin-B (a) and ketoconazole (b) for wild-type, knockout, and complement
strains of H. capsulatum. All data generated were performed with at least two
biological replicates. Data from seven replicates are graphed as mean  standard
error of the mean. All calculations were performed in GraphPad Prism.

Since the chosen antifungals inhibit ergosterol synthesis as previously described, we
chose to investigate any potential changes to the ergosterol synthesis pathway when DDR48
expression was absent. Figure 5 illustrates the differential expression of several ergosterol
synthesis genes in response to DDR48 knockout (all genes analyzed are presented in
Supplemental Figures) under optimal conditions. Interestingly, even in basal HMM conditions,
the absence of DDR48 resulted in dysregulation of some ergosterol synthesis genes, as seen with
Erg11a, Erg11b, and Erg6 (Figure 5a-c). Other genes in the pathway, like Erg25, exhibited
statistically insignificant changes in their transcriptional expression despite this gene knockout
(Figure 5d).
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Figure 4. DDR48 expression levels in the yeast morphotype are significantly
upregulated in response to antifungal stress. qRT-PCR assays were performed
on mold and yeast phase wild-type (DDR48 (+)) cells under optimal conditions
(control) and 0.25 hour, 0.5 hour, 1 hour, and 2 hours after the addition of 5 μg/ml
Amphotericin-B (a) or 50 μg/ml ketoconazole (b) to observe the expression of
DDR48. Histone H3 was used as a normalizer gene using the ΔΔct method to
normalize to the no Amphotericin- b (dashed lines) control. Data from triplicate
samples are graphed as mean ± standard error of the mean.

This led us to determine if DDR48 is acting as a regulator of the ergosterol synthesis pathway
and helping combat environmental stressors by helping maintain membrane integrity.
We treated wild-type, knockout, and complemented mutant cells with Amphotericin-B to
observe the effect on expression levels of ergosterol synthesis genes. Figure 6 shows several
genes in the ergosterol pathway that experienced dysregulation upon addition of the antifungal
drug for different treatment times before extraction. It is evident that different patterns occurred;
Erg11a experienced up-regulation upon deletion of DDR48, Erg2 experienced no significant
change in expression in knockout cells, and Erg25 and Erg26 were down-regulated in the
knockout. Additional qRT-PCR assays for other ergosterol genes analyzed can be found in the
Supplemental Figures section.
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Figure 5. Under optimal conditions, yeast phase H. capsulatum cells show
dysregulation of ergosterol synthesis genes in response to DDR48 deletion.
qRT-PCR assays were performed on yeast phase wild type, knockout, and
complement cells under optimal conditions to observe the expression of several
membrane sterol genes. Histone H3 was used as a normalizer gene using the ct
method to normalize to the no Amphotericin-B control (dashed lines). Data from
triplicate samples are graphed as mean  standard error of the mean.

Under Amphotericin-B stress in knockout cells, it appears that the genes analyzed lost
their ability to be transcribed, for the most part. This is evident by looking at Erg6, for example,
and visualizing how knockout cells failed to “turn on” this gene; that is, expression resembled
that of control wild-type cells throughout the stress assay. This was the case for most other genes
in the pathway, with the exception of Erg11a, which experienced significant up-regulation when
DDR48 was knocked out.
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Figure 6. Under Amphotericin-B stress, the deletion of DDR48 from H.
capsulatum alters expression of membrane sterol synthesis genes. qRT-PCR
assays were performed on yeast phase wild-type cells under optimal conditions
(control) and 0.25 hour, 0.5 hour, 1 hour, and 2 hours after the addition of 5 ug/mL
Amphotericin-B to observe the expression of several membrane sterol genes.
Histone H3 was used as a normalizer gene using the ct method to normalize to
the no Amphotericin-B control (dashed lines). Data from triplicate samples are
graphed as mean  standard error of the mean.
Figure 7 shows the ergosterol synthesis pathway with the results of our qRT-PCR
analyses (under Amphotericin-B stress) depicted as color-coded genes for the patterns of
expression changes observed. Genes shown in red font indicate those that experienced loss of
function or significant down-regulation as a result of DDR48 deletion. Genes shown in green
font indicate those that experienced up-regulation or gain of function. Genes shown in yellow
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font indicate those that experienced no significant change in expression compared to wild-type
expression.
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itraconazole)

Erg 24
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Figure 7. The ergosterol biosynthesis pathway showing the inhibitory mechanisms
of azole and Amphotericin-B therapies. Color coded genes depict expression
changes observed in ddr48 after treatment with Amphotericin-B. Genes that were
up-regulated are coded green, those that experienced no significant change are
shown in yellow, and down-regulated genes are indicated in red font.
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Chapter V: Conclusion
Through creation of a DDR48 deletion mutant strain, previous studies demonstrated that
DDR48-deficient C. albicans was susceptible to antifungal drugs including ketoconazole (Dib et
al., 2008). For this study, we chose to similarly investigate the impact of DDR48 on cell viability
under antifungal stressors in H. capsulatum and found that cells were more susceptible to
Amphotericin-B and ketoconazole when the gene was absent (Figure 3). Drug resistance was
restored in the complemented strain as demonstrated when MIC and IC50 values returned to wildtype levels.
In addition to combating cell stress in C. albicans, DDR48 has shown increased
transcription in S. cerevisiae in response to heat shock, osmotic stress, and DNA lesionproducing agents (Treger & McEntee, 1990). Similarly, in H. capsulatum, the up-regulation of
DDR48 after antifungal drug exposure confirmed our hypothesis that the gene plays some role in
combating cell stress in the organism. The yeast morphotype, specifically, saw an increase in
DDR48 expression in response to these stressors, which is of particular interest since this phase
is predominant in pathogenesis. One hypothesis we propose to distinguish the basal expression
patterns of DDR48 in the mold and yeast phases involves the natural environment of the mold
phase; since this phase is found in nature where there are many stressors acting on the cells at all
times, the increased basal-level transcription seen in Figure 1a may possibly be a result. The
yeast phase, grown in vitro, is not exposed to the same level of stress and may therefore lack the
number of DDR48 transcripts that the mold phase exhibits. However, when stressed with
antifungals, DDR48 expression increased to combat the stress, while the gene is already “turned
on” in the mold phase to combat natural, environmental stressors (Figure 4).
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Our study of transcriptional changes in ergosterol synthesis genes in response to DDR48
deletion resulted in novel discoveries regarding DDR48’s potential role in membrane
maintenance in H. capsulatum. When knockout cells were stressed with Amphotericin-B,
differential regulation of the sterol synthesis genes occurred (Figure 6). As noted previously,
Amphotericin-B stress acts at the end of the ergosterol synthesis pathway (Figure 7) by binding
to ergosterol to induce cell death (Figure 1). By depleting ergosterol, the cell might attempt to
produce more of the sterol to maintain membrane integrity and promote viability. However,
when DDR48 was deleted from the genome, it appeared that the majority of the genes in the
pathway, with the exception of Erg11a, could not be transcribed to wild-type levels. Thus, it
appears that DDR48 is acting somewhere upstream of the ergosterol synthesis pathway as a
regulatory gene, thereby resulting in transcriptional issues downstream when it is deleted from
the cell.
A study by DuBois and Smulian in 2016 showed that the sterol regulatory element
binding protein (SREBP), Srb1 is required for maximum transcription efficiency of several
ergosterol synthesis genes including Erg2, Erg3, Erg11a, and Erg25. Our data showed that in
DDR48-deficient cells under Amphotericin-B stress, Erg2 was expressed at nearly wild-type
levels, indicating that DDR48 may act even upstream of Srb1 to affect ergosterol synthesis
genes. This further indicates DDR48 as a gene potentially responsible for more global regulatory
mechanisms of the stress response in H. capsulatum if it operates upstream of Srb1.
The presented findings suggest that DDR48 may be responsible for viability of H.
capsulatum cells under stress-inducing agents. This indicates the gene as a potential target for
antifungal drug design in the future. By targeting DDR48, future antifungals may dampen the
stress response of the cell enough to allow macrophages to engulf and successfully degrade H.
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capsulatum cells. Thus, severe cases of histoplasmosis may be prevented, especially in
immunocompromised patients. Additional studies may aim to elucidate further the identity and
mechanism of action of the DDR48 protein or even visualize its location in the cell. However,
this study successfully verified that the gene is involved in combating cellular stressors, in part
by regulating membrane sterol genes by some mechanism upstream of the biosynthesis pathway.
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Chapter VI: Supplemental Figures
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S1. (a-h) Additional ergosterol synthesis genes analyzed under optimal conditions in
response to DDR48 deletion.
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